Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.51% | $292.76M | €450.59B | 80.13% | 76 Outperform | |
| AstraZeneca | 1.99% | $165.47M | $295.60B | 19.89% | 80 Outperform | |
| Novartis AG | 1.97% | $164.29M | CHF230.97B | 25.96% | 80 Outperform | |
| Roche Holding AG | 1.92% | $160.13M | CHF256.31B | 21.75% | 73 Outperform | |
| HSBC Holdings | 1.81% | $150.66M | £202.74B | 35.68% | 80 Outperform | |
| Nestlé SA | 1.78% | $148.08M | CHF204.54B | -0.11% | 71 Outperform | |
| Shell (UK) | 1.73% | $144.52M | £189.65B | 27.87% | 73 Outperform | |
| SAP SE | 1.34% | $111.80M | €189.51B | -30.51% | 66 Neutral | |
| Siemens | 1.29% | $107.24M | €167.96B | -4.39% | 74 Outperform | |
| TotalEnergies SE | 1.11% | $92.88M | €154.71B | 25.67% | 78 Outperform |